Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies.

Egea J, López-Muñoz F, Fernández-Capetillo O, Reiter RJ, Romero A

Front. Pharmacol. 13 (-) 873197 [2022-03-23; online 2022-03-23]

PubMed 35401215

DOI 10.3389/fphar.2022.873197

Crossref 10.3389/fphar.2022.873197

pmc: PMC8984144
pii: 873197


Publications 9.5.1